Supernus Sues Apotex for Infringement of Oxtellar XR® Patents Read more about Supernus Sues Apotex for Infringement of Oxtellar XR® Patents
Supernus Completes Acquisition of CNS Portfolio from US WorldMeds Read more about Supernus Completes Acquisition of CNS Portfolio from US WorldMeds
Supernus to Present at the Jefferies Virtual Health Care Conference Read more about Supernus to Present at the Jefferies Virtual Health Care Conference
Supernus Announces Paragraph IV ANDA Filing for Oxtellar XR® Read more about Supernus Announces Paragraph IV ANDA Filing for Oxtellar XR®
Supernus Announces First Quarter 2020 Financial Results Read more about Supernus Announces First Quarter 2020 Financial Results
Supernus to Acquire CNS Portfolio from US WorldMeds Read more about Supernus to Acquire CNS Portfolio from US WorldMeds
Supernus to Host First Quarter Results Earnings Conference Call Read more about Supernus to Host First Quarter Results Earnings Conference Call
Supernus and Navitor Announce Development and Option Agreement for Orally Active mTORC1 Activator NV-5138 Read more about Supernus and Navitor Announce Development and Option Agreement for Orally Active mTORC1 Activator NV-5138
Supernus to Present at the 2020 Cowen Health Care Conference Read more about Supernus to Present at the 2020 Cowen Health Care Conference